| MeSH term | MeSH ID | Detail |
|---|---|---|
| Uremia | D014511 | 33 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Otitis Media | D010033 | 12 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Bacterial Infections | D001424 | 21 associated lipids |
| Hyperglycemia | D006943 | 21 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Osteomyelitis | D010019 | 10 associated lipids |
| Corneal Diseases | D003316 | 13 associated lipids |
chlortetracycline
chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.
Cross Reference
Introduction
To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with chlortetracycline?
chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with chlortetracycline
PubChem Associated disorders and diseases
What pathways are associated with chlortetracycline
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with chlortetracycline?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with chlortetracycline?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with chlortetracycline?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with chlortetracycline?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with chlortetracycline?
Mouse Model
Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with chlortetracycline
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| ROSE HM and KNEELAND Y | Aureomycin in the treatment of infectious diseases. | 1949 | Am. J. Med. | pmid:18148348 |
| GALT J and HUNTER RB | The effect of aureomycin on certain liver function tests and blood coagulation. | 1950 | Am. J. Med. Sci. | pmid:14783119 |
| REKERS PE and MARTI N | The effect of aureomycin and the flavonoid rutin on the splenectomized rat. | 1951 | Am. J. Med. Sci. | pmid:14799484 |
| GOLDMAN R | The effect of aureomycin upon Hodgkin's disease. | 1951 | Am. J. Med. Sci. | pmid:14799485 |
| HERRELL WE | Aureomycin. | 1950 | Am. J. Med. Sci. | pmid:15410720 |
| Steigbigel NH et al. | Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. | 1968 | Am. J. Med. Sci. | pmid:4384524 |
| Fedorko J et al. | In vitro activity of minocycline, a new tetracycline. | 1968 | Am. J. Med. Sci. | pmid:4385129 |
| MOUNTAIN DC and KRUMENACHER FP | Oral undecylinic acid in the prevention of the so-called monilial complications secondary to the use of aureomycin, chloramphenicol and terramycin. | 1953 | Am. J. Med. Sci. | pmid:13030464 |
| CRONK GA | Aureomycin in infectious mononucleosis; a control study. | 1951 | Am. J. Med. Sci. | pmid:14885179 |
| SHEAR L et al. | INTRAPERITONEAL ANTIBIOTIC ADMINISTRATION: RATE OF ABSORPTION ACROSS NORMAL PERITONEUM. | 1965 | Am. J. Med. Sci. | pmid:14254824 |
| LEPPER MH et al. | Comparison of results of treatment of pneumococcic infections in mice with multiple doses of aureomycin and penicillin combined compared with each drug alone. | 1953 | Am. J. Med. Sci. | pmid:13057859 |
| JACKSON GG et al. | Antagonism and addition from combinations of aureomycin and penicillin in the treatment of pneumococcic infections in mice. | 1953 | Am. J. Med. Sci. | pmid:13040338 |
| WALKER SH | The failure of antibiotic therapy in infectious mononucleosis. | 1953 | Am. J. Med. Sci. | pmid:13065284 |
| SHAFFER JM et al. | Studies on the use of aureomycin in hepatic disease. I. Aureomycin therapy in acute viral hepatitis. | 1950 | Am. J. Med. Sci. | pmid:15425508 |
| GYORGY P et al. | Studies on the use of aureomycin in hepatic disease. II. The effect of aureomycin on experimental dietary hepatic necrosis. | 1950 | Am. J. Med. Sci. | pmid:15425509 |
| BLODGETT WA and SCHILLING FJ | The effect of aureomycin on venous clotting time. | 1951 | Am. J. Med. Sci. | pmid:14829472 |
| FARQUHAR JD et al. | Studies on the use of aureomycin in hepatic disease. III. A note on aureomycin therapy in hepatic coma. | 1950 | Am. J. Med. Sci. | pmid:15432452 |
| SHAFFER JM et al. | Studies on the use of aureomycin in hepatic disease. IV. Aureomycin therapy in chronic liver disease; with a note on dermal sensitivity. | 1950 | Am. J. Med. Sci. | pmid:15432453 |
| HESSELTINE HC and PRIDDLE HD | The use of aureomycin in obstetrics and gynecology. | 1951 | Am. J. Obstet. Gynecol. | pmid:14846838 |
| NAYFIELD RC | The role of aureomycin in the production of pruritus vulvae. | 1951 | Am. J. Obstet. Gynecol. | pmid:14857093 |